Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Harpoon Therapeutics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-09-22
Purchase
2021-09-22
9:30 pm
Harpoon Therapeutics Inc. HARP Erbez Georgia
CFO
10,300 $8.1 $83,430 98,207
(Indirect
Direct)
View
2021-01-11
Purchase
2021-08-12
4:15 pm
Harpoon Therapeutics Inc. HARP New Leaf Ventures III L.P.
New Leaf Venture Associates III L.P.
New Leaf Venture Management III L.L.C.
New Leaf Biopharma Opportunities II L.P.
New Leaf BPO Associates II L.P.
New Leaf BPO Management II L.L.C
10% Owner
235,294 $17 $3,999,998 3,156,699
(Indirect)
View
2021-01-11
Purchase
2021-08-12
4:15 pm
Harpoon Therapeutics Inc. HARP HUNT RONALD
Director
10% Owner
235,294 $17 $3,999,998 3,156,699
(Indirect)
View
2021-07-01
Sale
2021-07-06
6:01 pm
Harpoon Therapeutics Inc. HARP Wesche Holger
Chief Scientific Officer
10,000 $14 $140,000 73,854
(Direct)
View
2021-05-28
Sale
2021-06-02
6:09 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
57,494 $20.63 $1,186,190 6,328,095
(Indirect)
View
2021-05-26
Sale
2021-05-27
7:40 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
17,159 $20.22 $346,938 6,385,589
(Indirect)
View
2021-05-21
Sale
2021-05-24
8:11 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
15,907 $20.18 $321,030 6,402,748
(Indirect)
View
2021-05-18
Sale
2021-05-20
7:20 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
47,948 $20.49 $982,227 6,418,655
(Indirect)
View
2021-05-13
Sale
2021-05-17
5:23 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
16,421 $20.05 $329,314 6,466,603
(Indirect)
View
2021-05-10
Sale
2021-05-12
6:09 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
68,262 $21.04 $1,436,556 6,483,024
(Indirect)
View
2021-05-05
Sale
2021-05-06
4:05 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
10,172 $22.52 $229,107 6,551,286
(Indirect)
View
2021-04-30
Sale
2021-05-04
5:43 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
328,519 $22.48 $7,386,435 6,561,458
(Indirect)
View
2021-04-27
Sale
2021-04-29
5:46 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
130,143 $21.99 $2,861,368 6,889,977
(Indirect)
View
2021-04-21
Sale
2021-04-22
4:04 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
8,972 $18.97 $170,229 7,020,120
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-01-28
Option Award
2022-02-01
4:09 pm
N/A
2032-01-27
Harpoon Therapeutics Inc. HARP Wesche Holger
Chief Scientific Officer
135,000 $0 135,000
(Direct)
View
2022-01-28
Option Award
2022-02-01
4:07 pm
N/A
2032-01-27
Harpoon Therapeutics Inc. HARP Sacks Natalie
Chief Medical Officer
155,000 $0 155,000
(Direct)
View
2022-01-28
Option Award
2022-02-01
4:05 pm
N/A
2032-01-27
Harpoon Therapeutics Inc. HARP Erbez Georgia
CFO
115,000 $0 115,000
(Direct)
View
2021-11-11
Option Award
2021-11-15
4:04 pm
N/A
2031-11-11
Harpoon Therapeutics Inc. HARP Wesche Holger
Chief Scientific Officer
135,000 $0 135,000
(Direct)
View
2021-11-11
Option Award
2021-11-15
4:03 pm
N/A
2031-11-11
Harpoon Therapeutics Inc. HARP Sacks Natalie
Chief Medical Officer
155,000 $0 155,000
(Direct)
View
2021-11-11
Option Award
2021-11-15
4:02 pm
N/A
2031-11-11
Harpoon Therapeutics Inc. HARP Erbez Georgia
CFO
115,000 $0 115,000
(Direct)
View
2021-11-08
Option Award
2021-11-09
4:02 pm
N/A
2031-11-08
Harpoon Therapeutics Inc. HARP EASTLAND JULIA MARIE
CEO
350,000 $0 350,000
(Direct)
View
2021-10-25
Option Award
2021-10-26
4:22 pm
N/A
2031-10-25
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-07-01
Exercise
2021-07-06
6:01 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP Wesche Holger
Chief Scientific Officer
10,000 $0.6 73,854
(Direct)
View
2021-07-01
Exercise
2021-07-06
6:01 pm
N/A
2026-04-06
Harpoon Therapeutics Inc. HARP Wesche Holger
Chief Scientific Officer
10,000 $0 73,854
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:09 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Viney Joanne L.
Director
12,738 $0 12,738
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:07 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP BAILES JOSEPH S
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:05 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Robbins Andrew R
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:03 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:02 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP EASTLAND JULIA MARIE
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
8:01 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP HUNT RONALD
Director
10% Owner
14,825 $0 14,825
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
7:59 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP DRACHMAN JONATHAN G
Director
10,167 $0 10,167
(Direct)
View
2021-05-04(A)
Option Award
2021-05-14
7:57 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Chin Mark
Director
12,605 $0 12,605
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:59 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Colowick Alan
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:59 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Viney Joanne L.
Director
12,820 $0 12,820
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:58 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP BAILES JOSEPH S
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:57 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Robbins Andrew R
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:56 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Myers Scott Dunseth
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:55 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP EASTLAND JULIA MARIE
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:54 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP HUNT RONALD
Director
10% Owner
14,974 $0 14,974
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:53 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP DRACHMAN JONATHAN G
Director
10,167 $0 10,167
(Direct)
View
2021-05-04
Option Award
2021-05-07
9:52 pm
N/A
2031-05-03
Harpoon Therapeutics Inc. HARP Chin Mark
Director
13,184 $0 13,184
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, Next